Coronary Artery Disease
EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy
In stable post-MI patients on evidence-based medical therapy, the combination of oral high-dose vitamins and chelation therapy compared with double placebo reduced clinically important cardiovascular events to an extent that was both statistically significant and of potential clinical relevance.
Assess Chelation Therapy (TACT)3 found that this treatment reduced clinical events in post–myocardial infarction (MI) patients, particularly in patients with
diabetes. Chelation therapy is often administered in conjunction with a regimen of oral high-dose vitamins and minerals.